GANCICLOVIR (Ranbaxy Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the GANCICLOVIR drug offered from Ranbaxy Pharmaceuticals Inc.. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | GANCICLOVIR |
| SUBSTANCE NAME: | GANCICLOVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-08-27 |
| END MARKETING DATE: | 0000-00-00 |
GANCICLOVIR HUMAN PRESCRIPTION DRUG Details:
| Item Description | GANCICLOVIR from Ranbaxy Pharmaceuticals Inc. |
| LABELER NAME: | Ranbaxy Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2003-08-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63304-636_3406db8a-5ae9-4120-94bd-036701adbeca |
| PRODUCT NDC: | 63304-636 |
| APPLICATION NUMBER: | ANDA076457 |
Other GANCICLOVIR Pharmaceutical Manufacturers / Labelers:
